Single nucleotide polymorphisms (SNPs) in MHC class I and II genes to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3, MAVERICC, and TRIBE trials.

Authors

null

Pooja Mittal

Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA

Pooja Mittal , Francesca Battaglin , Yan Yang , Joshua Millstein , Sebastian Stintzing , Aparna Raj Parikh , Shivani Soni , Jae Ho Lo , Lesly Torres-Gonzalez , Sandra Algaze , Priya Jayachandran , Karam Ashouri , Alexandra Wong , Wu Zhang , Christoph Mancao , Chiara Cremolini , Volker Heinemann , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 3578)

DOI

10.1200/JCO.2023.41.16_suppl.3578

Abstract #

3578

Poster Bd #

278

Abstract Disclosures